Trends in mortality from non-Hodgkin’s lymphomas

Levi, Fabio; Lucchini, Franca; Negri, Eva; Vecchia, Carlo La

« Previous Next »Leukemia Research
Volume 26, Issue 10 , Pages 903-908, October 2002

Trends in mortality from non-Hodgkin’s lymphomas

Fabio Levi
- Cancer Epidemiology Unit and Cancer Registries of Vaud and Neuchâtel, Institut Universitaire de Médecine, Sociale et Préventive, CHUV-Falaises 1, 1011 Lausanne, Switzerland
- Corresponding author. Tel.: +41-21-314-73-11; fax: +41-21-323-03-03
Franca Lucchini
- Cancer Epidemiology Unit and Cancer Registries of Vaud and Neuchâtel, Institut Universitaire de Médecine, Sociale et Préventive, CHUV-Falaises 1, 1011 Lausanne, Switzerland
Eva Negri
- Laboratory of Epidemiology, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Via Eritrea 62, 20157 Milan, Italy
Carlo La Vecchia
- Laboratory of Epidemiology, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Via Eritrea 62, 20157 Milan, Italy
- Istituto di Statistica Medica e Biometria, Università degli Studi di Milano, Via Venezian 1, 20133 Milan, Italy

Received 19 December 2001; accepted 9 February 2002.

Abstract

Trends in death certification rates from non-Hodgkin’s lymphomas (NHL) were analyzed on the basis of the World Health Organization database over the period 1969–1998. Until the late 1970s, mortality from NHL was similar in the European Union (EU), the USA and Japan, i.e. around 3/100,000 males and 2/100,000 females. Over the last two decades, NHL mortality in the EU rose to 4.4/100,000 males and 2.8/100,000 females. Upward trends were greater in the USA, whose rates approached 6/100,000 males and 4/100,000 females in the late 1990s, and were observed in Japan, too.

Keywords: Lymphomas, Mortality, Trends